Literature DB >> 15972271

Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method.

Jason S Reingold1, Jonathan M McGavock, Shaheen Kaka, Tommy Tillery, Ronald G Victor, Lidia S Szczepaniak.   

Abstract

The primary aim of this investigation was to determine the reliability and sensitivity of 1H magnetic resonance spectroscopy (1H-MRS) as a method for quantifying myocardial triglyceride (TG) content in humans over time and in response to metabolic perturbations. Three separate experiments were designed to quantify myocardial TG content 1) over a 90-day period, 2) after a high-fat meal, and 3) after a 48-h fast. Proton spectra were collected from a 10 x 20 x 30-mm3 voxel placed within the intraventricular septum, with measurements acquired at end-systole and end-expiration, using cardiac triggering and respiratory gating. Minimal variation was observed between myocardial TG content determined 90 days apart (r = 0.98, CV = 5%), whereas TG values were unaffected by a high-fat meal despite a significant twofold increase (P < 0.05) in serum TG. In contrast, myocardial TG content increased threefold (P < 0.05) after a 48-h fast despite a 25% reduction in serum TG. Body mass index was significantly related to myocardial TG (r = 0.58, P < 0.05) and the change in myocardial TG after a 48-h fast (r2 = 0.60). 1H-MRS is a reliable method for the determination of myocardial TG in humans and is relatively unaffected by the consumption of one high-fat meal but sensitive to changes following a prolonged fast.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972271     DOI: 10.1152/ajpendo.00095.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  54 in total

Review 1.  Oxidative tissue: perilipin 5 links storage with the furnace.

Authors:  Hong Wang; Carole Sztalryd
Journal:  Trends Endocrinol Metab       Date:  2011-05-31       Impact factor: 12.015

2.  Insulin resistance is not associated with myocardial steatosis in women.

Authors:  M Krššák; Y Winhofer; C Göbl; M Bischof; G Reiter; A Kautzky-Willer; A Luger; M Krebs; C Anderwald
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

3.  Limits of a localized magnetic resonance spectroscopy assay for ex vivo myocardial triacylglycerol.

Authors:  Robert D O'Connor; Robert J Gropler; Linda Peterson; Jean Schaffer; Joseph J H Ackerman
Journal:  J Pharm Biomed Anal       Date:  2007-09-01       Impact factor: 3.935

4.  Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes.

Authors:  Ildiko Lingvay; Erin D Roe; Jonathan Duong; David Leonard; Lidia S Szczepaniak
Journal:  J Investig Med       Date:  2012-10       Impact factor: 2.895

5.  Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.

Authors:  Janet Wei; Michael D Nelson; Edward W Szczepaniak; Laura Smith; Puja K Mehta; Louise E J Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz; Lidia S Szczepaniak
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-30       Impact factor: 4.733

6.  Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

Authors:  Chia-Ying Liu; David A Bluemke; Gary Gerstenblith; Stefan L Zimmerman; Ji Li; Hong Zhu; Shenghan Lai; Hong Lai
Journal:  Int J Cardiol       Date:  2014-01-24       Impact factor: 4.164

7.  Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.

Authors:  Tomas G Neilan; Kim-Lien Nguyen; Vlad G Zaha; Kara W Chew; Leavitt Morrison; Ntobeko A B Ntusi; Mabel Toribio; Magid Awadalla; Zsofia D Drobni; Michael D Nelson; Tricia H Burdo; Marije Van Schalkwyk; Paul E Sax; Daniel J Skiest; Karen Tashima; Raphael J Landovitz; Eric Daar; Alysse G Wurcel; Gregory K Robbins; Robert K Bolan; Kathleen V Fitch; Judith S Currier; Gerald S Bloomfield; Patrice Desvigne-Nickens; Pamela S Douglas; Udo Hoffmann; Steven K Grinspoon; Heather Ribaudo; Rodney Dawson; Matthew Bidwell Goetz; Mamta K Jain; Alberta Warner; Lidia S Szczepaniak; Markella V Zanni
Journal:  J Infect Dis       Date:  2020-07-09       Impact factor: 5.226

8.  A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study.

Authors:  Sophia Airhart; W Todd Cade; Hui Jiang; Andrew R Coggan; Susan B Racette; Kevin Korenblat; Catherine Anderson Spearie; Suzanne Waller; Robert O'Connor; Adil Bashir; Daniel S Ory; Jean E Schaffer; Eric Novak; Marsha Farmer; Alan D Waggoner; Víctor G Dávila-Román; Cylen Javidan-Nejad; Linda R Peterson
Journal:  J Clin Endocrinol Metab       Date:  2015-12-10       Impact factor: 5.958

9.  Assessment of myocardial triglyceride oxidation with PET and 11C-palmitate.

Authors:  Zulfia Kisrieva-Ware; Andrew R Coggan; Terry L Sharp; Carmen S Dence; Robert J Gropler; Pilar Herrero
Journal:  J Nucl Cardiol       Date:  2009-02-11       Impact factor: 5.952

Review 10.  Steatocholecystitis and fatty gallbladder disease.

Authors:  Chung-Jyi Tsai
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.